4.95

0.40% -0.02

Leonabio Inc (LONA)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.97

Aprire:

$4.99

Volume 24 ore:

7,313

Relative Volume:

0.08

Capitalizzazione di mercato:

$46.64M

Reddito:

Utile/perdita netta:

$-129.41M

Rapporto P/E:

-0.2055

EPS:

-24.0922

Flusso di cassa netto:

$-51.97M

1 W Prestazione:

-4.81%

1M Prestazione:

-15.96%

6M Prestazione:

-42.58%

1 anno Prestazione:

+0.00%

Intervallo 1D:

$4.88

$5.02

Intervallo di 1 settimana:

$4.69

$5.75

Portata 52W:

$2.21

$14.21

Leonabio Inc Stock (LONA) Company Profile

Nome

Leonabio Inc

Settore

Healthcare (1051)

Industria

Biotechnology (594)

Telefono

(425) 620-8501

Indirizzo

18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-05

Ultimi documenti SEC

LONA's Discussions on Twitter

Compare LONA vs VRTX, REGN, MRNA, ARGX, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LONA Leonabio Inc	4.95	46.64M	0	-129.41M	-51.97M	-24.09
VRTX Vertex Pharmaceuticals Inc	525.63	133.23B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	808.80	83.27B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	205.71	82.12B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	879.53	55.31B	4.16B	1.29B	734.26M	19.58
ONC Beone Medicines Ltd Adr	375.74	42.50B	5.76B	514.49M	1.10B	4.4813

Leonabio Inc Stock (LONA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-07-30	Aggiornamento	Citizens	Mkt Perform → Mkt Outperform
2026-05-27	Iniziato	Piper Sandler	Overweight
2026-02-26	Iniziato	Cantor Fitzgerald	Overweight
2026-02-19	Aggiornamento	Mizuho	Neutral → Outperform
2024-09-19	Downgrade	Mizuho	Outperform → Neutral
2024-09-04	Downgrade	BTIG Research	Buy → Neutral
2024-09-04	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2024-09-04	Downgrade	Rodman & Renshaw	Buy → Neutral
2024-08-19	Iniziato	Rodman & Renshaw	Buy
2022-10-17	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2022-07-07	Iniziato	Mizuho	Buy
2022-06-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2022-06-23	Downgrade	Jefferies	Buy → Hold
2022-06-23	Downgrade	Stifel	Buy → Hold
2022-05-10	Iniziato	BTIG Research	Buy
2022-04-21	Iniziato	Berenberg	Buy
2021-12-15	Iniziato	Goldman	Neutral
2020-10-13	Iniziato	Goldman	Buy
2020-10-13	Iniziato	JMP Securities	Mkt Outperform
2020-10-13	Iniziato	Jefferies	Buy
2020-10-13	Iniziato	Stifel	Buy

Mostra tutto

Leonabio Inc Borsa (LONA) Ultime notizie

Sep 23, 2026

LeonaBio Opens Warrant Exercise Window for New Capital - The Globe and Mail

Sep 23, 2026

Sep 11, 2026

LeonaBio at Cantor healthcare conference: bets on ESR1 combo edge By Investing.com - Investing.com South Africa

Sep 11, 2026

LeonaBio at Cantor healthcare conference: bets on ESR1 combo edge By Investing.com - Investing.com India

Sep 11, 2026

LeonaBio at Cantor healthcare conference: bets on ESR1 combo edge By Investing.com - Investing.com Canada

Sep 11, 2026

Sep 06, 2026

LeonaBio (LONA) Stock Analysis Report | Financials & Insights - Benzinga España

Sep 06, 2026

Sep 03, 2026

LeonaBio to Participate in Cantor Global Healthcare Conference 2026 - Yahoo Finance

Sep 03, 2026

A drug developer's New York fireside chat is set for Sept. 11 - Stock Titan

Sep 03, 2026

Aug 31, 2026

Perceptive Advisors LLC Expands LeonaBio Inc (LONA) Stake in Str - GuruFocus

Aug 31, 2026

Sermonix Pharmaceuticals Discloses Investment at LeonaBio, Inc. with 36.9% Stake - TradingView

Aug 31, 2026

Prefunded warrants drive Sermonix-led LeonaBio (LONA) share shakeup - Stock Titan

Aug 31, 2026

Aug 28, 2026

Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO), LeonaBio (LONA) and Solid Biosciences (SLDB) - The Globe and Mail

Aug 28, 2026

Aug 26, 2026

LeonaBio Reaches Key Phase 3 Enrollment Milestone - TipRanks

Aug 26, 2026

Aug 25, 2026

Perceptive's LeonaBio (NASDAQ: LONA) stake nears its ownership limit - Stock Titan

Aug 25, 2026

Aug 20, 2026

Anders Hove reports new passive stake in LeonaBio (LONA) - Stock Titan

Aug 20, 2026

Aug 19, 2026

LONA Maintained by Mizuho -- Price Target Lowered to $15.00 - GuruFocus

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Nigeria

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com South Africa

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com India

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx - Investing.com

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx By Investing.com - Investing.com Canada

Aug 19, 2026

Mizuho lowers LeonaBio stock price target on higher OpEx - Investing.com

Aug 19, 2026

Analysts Are Bullish on These Healthcare Stocks: Cooper Co (COO), LeonaBio (LONA) - The Globe and Mail

Aug 19, 2026

Aug 18, 2026

LeonaBio Reports Narrower Quarter Loss as Trial Progresses - sekbernews.id

Aug 18, 2026

LeonaBio: ELAINE-3 Enrollment Reaches 495 Of About 600 Patients As Up To $146 Million Of Warrant Proceeds Could Support Upcoming Milestones - Pulse 2.0

Aug 18, 2026

LeonaBio (LONA) Market Close: Closes 3.19% Higher at $7.96 at the Close; Level Check: the Price Remains Bounded by the Supplied Support and Resistance under the Current SnapshotLow Volatility Picks - vinanet.vn

Aug 18, 2026

Analysts Offer Insights on Healthcare Companies: Elicio Therapeutics (ELTX), EyePoint Pharmaceuticals (EYPT) and LeonaBio (LONA) - The Globe and Mail

Aug 18, 2026

Aug 17, 2026

LeonaBio price target lowered to $17 from $18 at Citizens - TipRanks

Aug 17, 2026